Trattamento Ormonale Dell'Adenocarcinoma Prostatico (Stadio C E D) Ed Emocoagulazione **

Baker H. W. G. , Burger H. G. , Kretser D. M. , Hudson B. , Rennie G. C. , Straffon W. G. : The assessment of results following endocrine therapy for prostatic cancer. J. Urol., 113; 824 (1975).

Blackard C. E. , Doe R. P. , Melliger G. T. , Byar D. P. : Incidence of cardiovascular disease and death in patients receiving diethylstilbestrol for carcinoma of the prostate. Cancer, 26; 249 (1970).

Blackard C. E. , Mellinger G. T. , Gleason D. F. : Treatment of carcinoma of the prostate: a preliminary report. J. Urol., 106; 729 (1971).

Breddin K. , Scharrer I. , Scheoping M. : Die Hemmung der Plättchenaggregation mit azetylsalizylsäure. Experimentelle und klinische Ergebnisse. Münch. Med. Wochenschr., 113; 1284 (1971).

Chohan I. S. , Vermylen J. , Singh I. , Balakrishnan K. , Verstraete M. : Sodium acetate buffer. A diluent of choice in the clot lysis time technique. Tromb. Diathes. Haemorrh., 33; 226 (1975).

Clayton J. K. , Anderson J. A. , McNicol G. P. : Preoperative prediction of postoperative deep vein thrombosis. Brit. Med. J., 2; 910 (1976).

Costantini A. , Doni A. , Rizzo M. , Panerai A. , Grechi G. , Bartoletti L. : Manifestazioni trombo-emorragiche di interesse urologico. Atti Soc. It. Urol., 1; 1 (1971).

Doobs R. M. , Barber J. A. , Weigel J. W. , Bergin J. E. : Clottig predisoosition in carcinoma of the crostate. J. Urol., 123; 706 (1970).

Eisen M. , Napp H. E. , Vock R. : Inhibition of platelet aggregation caused by estrogen treatment in patient with carcinoma of the prostate. J. Urol., 114; 93 (1975).

Lowe G. D. O. , McArdle B. M. , Carter D. C. , McLaren D. , Osborne D. H. , Smith A. , Forbes C. D. , Prentice C. R. M. : Prediction and selective prophylaxis of venous thrombosis in elective gastrointestinal surgery. Lancet. 2; 409 (1982).

Jennifer R. , Niebyl M. D. , William R. , Bell M. D. , Mary E. , Schaaf M. D. , David A. , Blake Ph. D., Norman H. , Dubin Ph. D., Theodore M. , King M. D. Ph. D.: The effect of chlorotrianisene as postpartum lactation suppression on blood coagulation factors. Amer. J. Obst. & Gynec., 134; 518 (1979).

Seal U. S. , Doe R. P. , Byar D. P. , Corle D. K. : Response of plasma fibrinogen and plasminogen to hormone treatment and the relation of treatment values to mortality in patient with prostatic cancer. Cancer, 38; 1108 (1976).

Stadel B. V. , Srenthal P. M. , Schlesselman J. J. : Variation of ethinylestradiol blood levels among healty women using oral contraceptives. Fertil. & Steril., 33; 257 (1980).

Straub P. W. , Riedler G. , Frick P. G. : Hypo-fibrinogenaemia in metastatic carcinoma of the prostate: suppression of systemic fibrinolysis by eparin. J. Clin. Pathol., 20; 152 (1967).

Wu K. K. , Hoak T. C. : A new metod for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet, 2; 924 (1974).